Pfam Domains GO Terms
| RRM 1 |
| ASAP complex |
| negative regulation of mRNA splicing, via spliceosome |
| exon-exon junction complex |
| negative regulation of RNA splicing |
| negative regulation of mRNA processing |
| regulation of alternative mRNA splicing, via spliceosome |
| mRNA 3-UTR binding |
| negative regulation of mRNA metabolic process |
| mRNA 3-end processing |
| regulation of mRNA splicing, via spliceosome |
| mRNA-containing ribonucleoprotein complex export from nucleus |
| mRNA export from nucleus |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay |
| ribonucleoprotein complex export from nucleus |
| ribonucleoprotein complex localization |
| RNA export from nucleus |
| RNA 3-end processing |
| regulation of RNA splicing |
| regulation of mRNA processing |
| protein export from nucleus |
| mRNA transport |
| nuclear export |
| RNA transport |
| nucleic acid transport |
| establishment of RNA localization |
| nuclear-transcribed mRNA catabolic process |
| RNA localization |
| mRNA catabolic process |
| nucleobase-containing compound transport |
| RNA catabolic process |
| protein-containing complex localization |
| nucleocytoplasmic transport |
| nuclear transport |
| mRNA splicing, via spliceosome |
| RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| RNA splicing, via transesterification reactions |
| regulation of mRNA metabolic process |
| nucleobase-containing compound catabolic process |
| RNA splicing |
| nuclear speck |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| aromatic compound catabolic process |
| mRNA processing |
| organic cyclic compound catabolic process |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| RNA biosynthetic process |
| mRNA metabolic process |
| positive regulation of cell death |
| RNA processing |
| cellular macromolecule catabolic process |
| intracellular protein transport |
| macromolecule catabolic process |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| organic cyclic compound biosynthetic process |
| negative regulation of RNA metabolic process |
| RNA binding |
| negative regulation of nucleobase-containing compound metabolic process |
| protein transport |
| intracellular transport |
| peptide transport |
| regulation of apoptotic process |
| regulation of programmed cell death |
| amide transport |
| cellular protein localization |
| cellular macromolecule localization |
| establishment of protein localization |
| cellular nitrogen compound biosynthetic process |
| RNA metabolic process |
| regulation of cell death |
| cellular macromolecule biosynthetic process |
| negative regulation of gene expression |
| macromolecule biosynthetic process |
| organic substance catabolic process |
| cellular catabolic process |
| establishment of localization in cell |
| nitrogen compound transport |
| gene expression |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 17/28 |
| blood | 17/28 |
| bone | 16/25 |
| breast | 20/33 |
| central nervous system | 30/56 |
| cervix | 0/4 |
| colorectal | 8/17 |
| esophagus | 6/13 |
| fibroblast | 1/1 |
| gastric | 7/15 |
| kidney | 9/21 |
| liver | 13/20 |
| lung | 37/75 |
| lymphocyte | 6/14 |
| ovary | 15/26 |
| pancreas | 13/24 |
| peripheral nervous system | 12/16 |
| plasma cell | 5/15 |
| prostate | 1/1 |
| skin | 16/24 |
| soft tissue | 3/7 |
| thyroid | 1/2 |
| upper aerodigestive | 4/22 |
| urinary tract | 10/29 |
| uterus | 2/5 |
Expression Distribution